A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

Medicus Pharma (NASDAQ:MDCX) announced that an independent assessment of its Phase 2 SkinJect study supports the clinical ...

What should patients do before their first skin check? According to a HelloNation article, small steps can make a big difference in ensuring a thorough exam. Dermatology Expert Dr. Lesley Loss of ...

An independent skin-cancer screening and mole-check provider will soon open a new Birmingham clinic. Located at 30A Harborne Road, Edgbaston, The Mole Clinic will provide single mole checks, full body ...

As dermatology continues to confront longstanding gaps in diagnosis and treatment across diverse populations, improving care ...

A review of published studies suggests that skin toxicities related to checkpoint inhibitors may be managed differently in ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...

Experience Advanced Skin Resurfacing with CoolPeel at Main Street Med Spa Clovis, United States - March 25, 2026 / Main ...

The role of in vitro testing in modern cosmetic development Ensuring the safety and performance of cosmetic products is a critical requirement for manufacturers operating in today’s regulated and ...

Guselkumab Q4W and Q8W showed comparable safety and efficacy for treating active PsA among patients with an inadequate response to 1 TNF inhibitor.

A first-in-class monoclonal antibody has shown significant reductions in skin disease in patients with cutaneous lupus erythematosus (CLE). Litifilimab met the primary endpoint of reduction of disease ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...